BDTX: Black Diamond Therapeutics Inc

FinancialsDividends

$3.04

0.09

(3.05%)

As of 07/16/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

BDTX Performance Snapshot


1-Week Chg

15.15%

1-Month Chg

27.20%

3-Month Chg

123.53%

6-Month Chg

37.56%

1-Year Chg

-51.05%

Year-To-Date Chg

42.06%

Beta 1-Year

2.39

Beta 5-Year

2.22

Volatility (10-Day)

6.95%

BDTX Technical Snapshot



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-07-16

$3.04

$0.09 (3.05%)

$2.95

$3.31

$2.93

$3.09

2.31M ($7.01M)

2025-07-15

$2.95

$0.01 (0.34%)

$2.95

$2.99

$2.84

$2.93

1.16M ($3.41M)

2025-07-14

$2.94

$0.07 (2.44%)

$2.87

$2.98

$2.81

$2.91

1.24M ($3.65M)

2025-07-11

$2.87

$0.13 (4.74%)

$2.71

$2.88

$2.70

$2.81

1.02M ($2.92M)

2025-07-10

$2.74

$0.10 (3.79%)

$2.65

$2.77

$2.62

$2.71

779.00K ($2.13M)

2025-07-09

$2.64

$0.14 (5.6%)

$2.50

$2.68

$2.49

$2.60

955.00K ($2.52M)

2025-07-08

$2.50

$0 (0%)

$2.50

$2.56

$2.46

$2.51

592.00K ($1.48M)

2025-07-07

$2.50

-$0.08 (-3.1%)

$2.50

$2.54

$2.43

$2.49

903.00K ($2.26M)

2025-07-03

$2.58

-$0.02 (-0.77%)

$2.63

$2.65

$2.54

$2.59

472.00K ($1.22M)

2025-07-02

$2.60

$0.12 (4.84%)

$2.48

$2.71

$2.43

$2.58

1.40M ($3.64M)

BDTX Financial Snapshot


Balance Sheet

(USD)

2025 Q1

Y/Y CHANGE


  • Cash and equivalents

    $99.25M

    278.21%

  • Total assets

    $176.25M

    23.66%

  • Total liabilities

    $34.73M

    -9.12%

  • Total investments

    $53.98M

    -39.88%

  • Shareholders' equity

    $141.52M

    35.67%

  • Book value per share

    $2.50

    24.04%


Income Statement

(USD)

2025 Q1

Y/Y CHANGE


  • Revenue

    $70.00M

    -

  • Net income

    $56.54M

    410.24%

  • Operating expense

    $15.47M

    -23.59%

  • Gross profit

    $70.00M

    -

  • EBITDA

    $56.63M

    412.19%

  • Earnings per share

    $1

    385.71%


Cash Flow

(USD)

2025 Q1

Y/Y CHANGE


  • Net change in cash

    $61.99M

    301.24%

  • Cash from operations

    $53.41M

    351.95%

  • Cash from investing

    $8.55M

    162.23%

  • Cash from financing

    $32.00K

    -99.23%

  • Free cash flow

    $53.42M

    352.01%

  • Free cash flow per share

    $0.94

    330.56%


Metrics

(USD)

2025 Q1

Y/Y CHANGE


  • Market capitalization

    $87.83M

    -66.51%

  • Enterprise value

    $69.35M

    -69.50%

  • Shares outstanding

    56.66M

    9.56%

  • Profit margin

    80.80%

    -

  • Gross margin

    100.00%

    -

  • EBITDA margin

    80.90%

    -


Dividends

(USD)

2025 Q1

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    9.24

    31.10%